Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015969
Filing Date
2023-05-01
Accepted
2023-04-28 17:43:07
Documents
25

Document Format Files

Seq Description Document Type Size
1 DEF 14A acad-20230428.htm   iXBRL DEF 14A 3652787
2 GRAPHIC img236278225_0.jpg GRAPHIC 5236
3 GRAPHIC img236278225_1.jpg GRAPHIC 11677
4 GRAPHIC img236278225_2.jpg GRAPHIC 11677
5 GRAPHIC img236278225_3.jpg GRAPHIC 2081
6 GRAPHIC img236278225_4.jpg GRAPHIC 62951
7 GRAPHIC img236278225_5.jpg GRAPHIC 39610
8 GRAPHIC img236278225_6.jpg GRAPHIC 37255
9 GRAPHIC img236278225_7.jpg GRAPHIC 32650
10 GRAPHIC img236278225_8.jpg GRAPHIC 13811
11 GRAPHIC img236278225_9.jpg GRAPHIC 53771
12 GRAPHIC img236278225_10.jpg GRAPHIC 67013
  Complete submission text file 0000950170-23-015969.txt   6026037

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acad-20230428_pre.xml EX-101.PRE 6948
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acad-20230428_lab.xml EX-101.LAB 10874
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acad-20230428.xsd EX-101.SCH 5127
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acad-20230428_def.xml EX-101.DEF 5407
19 EXTRACTED XBRL INSTANCE DOCUMENT acad-20230428_htm.xml XML 641178
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50768 | Film No.: 23868762
SIC: 2834 Pharmaceutical Preparations